Drug Topics

JUNE 19, 2025

FDA Grants Interchangeability Designation to Adalimumab-Bwwd for Humira Ashley Gallagher May 28th 2025 Article This designation follows Hadlima’s low-concentration prefilled syringes and single-dose vials, which were designated in June 2024.

FDA 307

FDA Specialty Pharmacies Compounding Independent Pharmacies 307

Drug Topics

JUNE 9, 2025

2024 Dec 10;84(24):2393-2403. Epub 2024 Aug 31. 2024 Oct 19;404(10462):1536-1546. Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension. J Am Coll Cardiol. doi: 10.1016/j.jacc.2024.08.025. 2024.08.025. PMID: 39217570. doi: 10.1016/S0140-6736(24)01744-6.

FDA 281

FDA Compounding Specialty Pharmacies Communication 281

Drug Topics

JUNE 11, 2025

From 1980 to 2024, the National Centers for Environmental Information reported 403 confirmed natural disaster events impacting weather or climate, totaling economic losses over $1 billion. One of the most recent natural disasters was the late-2024 and early-2025 Los Angeles wildfires.

Health and Personal Care Stores 315

Health and Personal Care Stores Community Pharmacies Independent Pharmacies Communication 315

Drug Topics

JUNE 18, 2025

Published 2024 Nov 25. Eggers S, Hoggarth ZE, Nagdeo K, et al. Food Insecurity Modifies the Association Between the Gut Microbiome and the Risk of Cognitive Impairment in Adults. rs-5486286. doi:10.21203/rs.3.rs-5486286/v1 rs-5486286/v1 3. Nowosielski B, Gupta V. Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025.

Communication 347

Communication Compounding Specialty Pharmacies Independent Pharmacies 347

Drug Topics

JUNE 6, 2025

Additionally, pharmacists can make sure that patients have updated immunizations, especially for patients who are on immunosuppressive therapy. December 18, 2024. Disease management—such as medication, surgery, and diet—was prevalent in 32% of videos. They can provide support for adherence, monitor safety, and educate patients.

FDA 281

FDA Immunization Mayo Clinic Dosage 281

Drug Topics

JUNE 20, 2025

The search included articles between January 2013 and June 2024. 1 “In line with the goals of its Immunization Agenda 2030, WHO has identified a new list of 17 high-priority global endemic pathogens for vaccine research and development, of which skin pathogens account for at least 8, reinforcing the need for continued focus in this area.”

Vaccines 247

Vaccines Independent Pharmacies Immunization Compounding 247

Drug Topics

DECEMBER 19, 2023

In January 2024, Sanofi and AstraZenenca will release 230,000 additional doses of nirsevimab-alip, heeding guidance from the CDC to leverage all tools to increase immunizations against RSV.

Immunization 247

Immunization 247

Pharmacy Times

SEPTEMBER 13, 2023

The CDC emphasized the need for protein-based vaccine options in endorsing a vote by the Advisory Committee on Immunization Practices for the universal recommendation of the 2023-2024 monovalent, XBB containing COVID-19 vaccines.

Vaccines 139

Vaccines Immunization 139

Pharmacy Times

SEPTEMBER 25, 2023

For community pharmacists, cooler temperatures, school buses on the roads and Friday night football are not just signs of a changing season – they are indicators that patients will soon be seeking vaccinations for the 2023-2024 respiratory illness season.

Vaccines 148

Vaccines Immunization 148

Pharmacy Times

JANUARY 22, 2024

The schedule includes RSV vaccination, along with updated versions of the COVID-19 vaccine.

Vaccines 127

Vaccines Immunization 127

Pharmacy Times

DECEMBER 11, 2024

Assessing pre-treatment TIL levels in young breast cancer patients could help predict response to neoadjuvant chemotherapy.

Immunization 130

Immunization Chemotherapy 130

Drug Topics

JUNE 12, 2025

Published 2024 Sep 12. Cho EJ, Chung GE, Yoo JJ, et al. Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups. Cardiovasc Diabetol. 2024;23(1):340. doi:10.1186/s12933-024-02408-7 4. Nonalcoholic Fatty Liver Disease in Diabetes: A Call to Action. Diabetes Spectr. 2024;37(1):5-7.

Compounding 247

Compounding Specialty Pharmacies Independent Pharmacies Immunization 247

STAT

OCTOBER 14, 2024

Companies that are developing new medicines for autoimmune conditions, as well as other immune system disorders, have brought in more money and closed more deals so far this year than most other areas, including the cardiometabolic field, data from investment bank Oppenheimer show.

Immunization 144

Immunization 144

Pharmafile

APRIL 11, 2024

Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share, totaling an approximate $4.9bn. The transaction has been approved by both companies’ board of directors and is expected to close later in the second quarter of 2024.

Immunization 59

Immunization 59

Fierce Pharma

JANUARY 2, 2024

AstraZeneca and Sanofi have scored first in | AstraZeneca and Sanofi have scored first in China with an approval for their respiratory syncytial virus (RSV) immunization Beyfortus for infants, with the companies expecting the shot to be available there for the 2024-25 season.

Immunization 117

Immunization 117

Fierce Pharma

JULY 31, 2024

The whole respiratory syncytial virus (RSV) vaccine field took a beating when the Centers for Disease Control and Prevention’s (CDC's) immunization committee doled out a limited recommendation last | The whole RSV vaccine field took a beating when the CDC’s immunization committee doled out a limited recommendation last month.

Vaccines 105

Vaccines Immunization 105

The Checkup by Singlecare

NOVEMBER 26, 2024

Vitamin D Vitamin D coupons Most people think of vitamin D as the sunshine vitamin without realizing how big of an impact it has on our immune system. Low levels of vitamin D have been linked to poor immune function and fatigue, which can inhibit your recovery from COVID, says Simpson. Who should avoid vitamins for post-COVID fatigue?

Immunization 94

Immunization Hospitals FDA 94

Fierce Pharma

MAY 2, 2024

With Moderna’s COVID-19 sales on the backfoot following the switch to an endemic vaccine market, the Massachusetts-based biopharma is busy laying the groundwork for its next potential mRNA shot in | Moderna currently expects initial approvals of its RSV vaccine to start rolling in during the first half of 2024, the company said Thursday.

Vaccines 111

Vaccines Immunization 111

The Thyroid Pharmacist

DECEMBER 29, 2023

I am hoping to feel more settled in 2024. I am wrapping up some projects in early 2024 and I am carving out more time for myself and my own healing. Adaptogens may also be anti-inflammatory, neuroprotective, and supportive of a healthy immune function. Does Adrenal Fatigue Exist? Gut Recovery Program (est.

Adverse Reactions 80

Adverse Reactions Immunization Dosage 80

pharmaphorum

APRIL 10, 2024

billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA nephropathy (IgAN). It is the largest acquisition in the biopharma sector so far in 2024. In another departure from its focus on genetic medicines, Vertex Pharma has agreed a $4.9

Immunization 105

Immunization 105

European Pharmaceutical Review

MAY 14, 2024

Takeda and AC Immune SA have agreed a global option and license agreement for a potential first-in-class Abeta-targeting active immunotherapy for Alzheimer’s. AC Immune’s related immunotherapies targeting Abeta are part of the deal, including the Alzheimer’s treatment ACI-24.060.

Immunization 97

Immunization 97

Pharmacy Times

JUNE 20, 2025

Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease. Kobayashi M, Leidner AJ, Gierke R, et al. MMWR Morb Wkly Rep. 2025;74:1-8. doi:10.15585/mmwr.mm7401a1 3.

Vaccines 65

Vaccines Immunization Compounding Pharmacies Hospitals 65

Digital Pharmacist

DECEMBER 20, 2023

A few types of free screenings you could offer: Wellness exams Full cholesterol panels Blood pressure and glucose screenings Health screenings also offer a jumping-off point for promoting other healthcare services, such as senior immunizations for conditions like shingles and pneumonia, or flu shots.

Communication 98

Communication Immunization 98

European Pharmaceutical Review

JANUARY 11, 2024

Ustekinumab biologic Once the European Supplementary Protection Certificate (SPC) for Stelara expires in July 2024, this will open up market entry as soon as possible for Uzpruvo, now that it is approved in Europe” Ustekinumab is a human IgG1κ monoclonal antibody (mAb).

Immunization 115

Immunization 115

PQA

NOVEMBER 14, 2024

November 7-8, 2024, for the 2024 PQA Leadership Summit. PQA also announced five students who completed the 2024 PQA Healthcare Quality IQ (HQIQ), sponsored by PQA by Innovaccer. PQA members gathered in Arlington, Va., The summit focused on PQA's recent and ongoing work to develop standard pharmacy quality measures.

Specialty Pharmacies 52

Specialty Pharmacies Documentation Patient Care Immunization 52

European Pharmaceutical Review

JANUARY 2, 2024

The transaction is expected to close in the first quarter of 2024, subject to certain closing conditions. Data showed that 18 percent of industry professionals believed this to be the case, with personalised medicine predicted as the top trend in 2024, according to 16 percent of the respondents.

Immunization 98

Immunization 98

The Checkup by Singlecare

JANUARY 11, 2024

10 potential upcoming FDA approvals for 2024 Pharmacists are on the frontline when it comes to getting patients the right medications for their treatment plan. Therefore, you’ll want to prepare and adapt to potential 2024 FDA approvals, which may include the following drugs currently in the pipeline. g/dL versus 0.50

FDA 52

FDA Immunization Patient Care Packaging 52

Pharmaceutical Technology

JUNE 13, 2025

The technology utilises outer membrane vesicles (OMVs) to deliver antigens, often eliminating the need for adjuvants while triggering the immune response. Discovered and developed by GSK’s global health team scientists, the GMMA technology is a low-cost platform ideal for creating vaccines in resource-limited settings.

Vaccines 87

Vaccines Communication Hospitals Packaging 87

PQA

SEPTEMBER 12, 2023

The Pharmacy Quality Alliance (PQA) seeks interested pharmacy and payer partners to participate in proof-of-concept pilots to implement and test high priority immunization pharmacy measure concepts. PQA has issued a request for interest (RFI) to gauge interest and willingness to participate in these pilots.

Immunization 40

Immunization Patient Care 40

European Pharmaceutical Review

JUNE 25, 2024

This indicates that the treatment can help to preserve important immune functions in the body. This one-year data for OCREVUS SC was presented in April this year at the 2024 American Academy of Neurology (AAN) Annual Meeting. percent, over 48 weeks of treatment.

Immunization 111

Immunization 111

pharmaphorum

SEPTEMBER 27, 2022

The principal is much the same as in checkpoint inhibitor treatment: preventing the cancer cells from evading detection by the body’s immune system and highlighting them for destruction by T cells. The ability for cancer cells to create this suppressive tumour microenvironment (TME) allows them to avoid detection by the immune system.

Vaccines 97

Vaccines Immunization 97

European Pharmaceutical Review

AUGUST 9, 2023

The pharmaceutical company announced that it plans to submit to global health authorities in 2024. There were 470 participants in the REMIX-1 study. In REMIX-2, the clinical trial enrolled 455 participants with CSU.

Immunization 94

Immunization Pharmaceutical Companies Pharmaceutical Companies 94

European Pharmaceutical Review

OCTOBER 25, 2024

the biologic has the potential to deliver anti-tumour responses in the majority of patients with ES-SCLC” The ongoing Phase I trial is assessing the antibody-drug conjugate both as a single treatment and as a combination therapy together with the immune checkpoint inhibitor atezolizumab.

Chemotherapy 97

Chemotherapy Compounding Immunization 97

BioPharm

MAY 10, 2024

Regeneron’s work in CAR-T cell therapy development includes engineering receptor architecture to improve CAR-T cell sensitivity and improve immune response.

Immunization 52

Immunization 52

European Pharmaceutical Review

APRIL 10, 2024

It also suggests the potential to use NX-5948 as a therapeutic option for immune indications with CNS involvement such as multiple sclerosis.” These data were presented at the 2024 American Association for Cancer Research (AACR) 2024 Annual Meeting.

Immunization 97

Immunization 97

PQA

DECEMBER 13, 2024

As wenearthe end of 2024,itsagreattimeto reflect on our accomplishments.We I want to share highlights from five major areas of work in 2024. Our August 2024 report, Advancing Medication Therapy Management Quality Measurement, describes critical actions necessary to advance the quality of MTM services.

Communication 52

Communication Patient Care Immunization 52

STAT

APRIL 11, 2024

Medicare actuaries expect the drug, which is called Leqembi and sold by Eisai in partnership with Biogen, to cost the traditional Medicare program around $550 million in 2024. That is projected to increase to $3.5 billion in 2025 for the entire Medicare program, a spokesperson for the Centers for Medicare and Medicaid Services confirmed.

Chemotherapy 106

Chemotherapy Immunization 106